KDM4-INHIBITOREN

European patent · EP3600301 · Deleted

Register entry

Publication number
EP3600301
Application number
EP18774276
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 27, 2018
Published
Feb 5, 2020
Granted
Jul 3, 2024
Deleted
Oct 23, 2025
Reason
Annual fee unpaid
IPC classes
C07D 213/79 (2006.01)
A61K 31/44 (2006.01)
A61P 25/00 (2006.01)
Priority
US 201762478785 P 30.03.2017
US 201762513875 P 01.06.2017
PCT application
PCT/US2018/024624 27.03.2018
PCT publication
WO2018/183370 04.10.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2025

  2. May 14, 2025

    Change

    Published in Swissreg on 14.05.2025

  3. Jul 3, 2024

    Granted

    Published in Swissreg on 03.07.2024

Parties

Holder

Celgene Quanticel Research, Inc.

9393 Towne Centre Drive, Suite 110, San Diego, CA 92121, US

Albert-Ludwigs-Universität Freiburg

Zentrale Klinische Forschung Breisacher Str. 66, 79106 Freiburg, DE

Inventor

METZGER, Eric

79106 Freiburg, DE

SCHÜLE, Roland

79106 Freiburg, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.